Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransUnion (TRU) Cash & Equivalents: 2011-2025

Historic Cash & Equivalents for TransUnion (TRU) over the last 14 years, with Sep 2025 value amounting to $749.9 million.

  • TransUnion's Cash & Equivalents rose 16.59% to $749.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $749.9 million, marking a year-over-year increase of 16.59%. This contributed to the annual value of $679.5 million for FY2024, which is 42.69% up from last year.
  • TransUnion's Cash & Equivalents amounted to $749.9 million in Q3 2025, which was up 9.08% from $687.5 million recorded in Q2 2025.
  • Over the past 5 years, TransUnion's Cash & Equivalents peaked at $1.8 billion during Q4 2021, and registered a low of $420.9 million during Q3 2023.
  • For the 3-year period, TransUnion's Cash & Equivalents averaged around $556.8 million, with its median value being $543.2 million (2024).
  • In the last 5 years, TransUnion's Cash & Equivalents soared by 273.94% in 2021 and then plummeted by 68.23% in 2022.
  • Quarterly analysis of 5 years shows TransUnion's Cash & Equivalents stood at $1.8 billion in 2021, then plummeted by 68.23% to $585.3 million in 2022, then dropped by 18.64% to $476.2 million in 2023, then spiked by 42.69% to $679.5 million in 2024, then rose by 16.59% to $749.9 million in 2025.
  • Its Cash & Equivalents was $749.9 million in Q3 2025, compared to $687.5 million in Q2 2025 and $609.9 million in Q1 2025.